BioSpace News Archive

The global healthcare additive manufacturing market size is projected to surpass around US$ 9.87 billion by 2030 from valued at US$ 1.65 billion in 2021, growing at a CAGR of 22% from 2021 to 2030.

Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, announced the appointment of Scott Saywell as Chief Business Officer.

M-Life’s™ Molecular Systems Approach is Proving Itself as the Next Generation for Drug Discovery.

Incidence of sports injuries has risen significantly in the last few years, when unwavering innovations of novel products and treatment modalities have also taken place.

Today, the U.S. Food and Drug Administration (FDA) cleared the new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that it will release its fourth quarter and full-year 2021 financial results on Thursday, March 17, 2022.

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today provided a business update and reported fourth quarter and full year 2021 financial results.

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Thursday, March 17, 2022 at 4:30 p.m. Eastern Time to discuss financial results for the fourth quarter and year ended December 31, 2021 and to provide a business update.

via NewMediaWire – Neovasc Inc. reported financial results for the fourth quarter and year ended December 31, 2021.

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, announced today its financial results for the fourth quarter and full year 2021 and provided a corporate update.